Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes

scientific article

Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1056/NEJMOA1401329
P932PMC publication ID5451259
P698PubMed publication ID24679060
P5875ResearchGate publication ID261217809

P50authorSteven NissenQ7615086
Sankar NavaneethanQ109544900
Stacy BrethauerQ114426598
Deepak L. BhattQ47264894
John P KirwanQ88081798
P2093author name stringKathy Wolski
Sangeeta R Kashyap
STAMPEDE Investigators
Ali Aminian
Claire E Pothier
Esther S H Kim
Philip R Schauer
P2860cites workEffects of Bariatric Surgery on Mortality in Swedish Obese SubjectsQ22250885
Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes MellitusQ24535547
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgeryQ29614192
Health benefits of gastric bypass surgery after 6 yearsQ30542947
Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitusQ33949927
Bariatric surgery and long-term cardiovascular events.Q34030064
Bariatric surgery versus conventional medical therapy for type 2 diabetesQ34263754
Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-upQ34583219
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysisQ34660044
Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for VQ34748094
Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic reviewQ34757695
Bariatric surgery: an IDF statement for obese Type 2 diabetesQ35069674
Bariatric surgery versus intensive medical therapy in obese patients with diabetesQ36025669
Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesityQ36047225
Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatmentQ37022586
Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.Q37638200
Interpreting different measures of glomerular filtration rate in obesity and weight loss: pitfalls for the clinician.Q37970042
Bariatric surgery and cardiovascular outcomes: a systematic review.Q38053138
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trialQ38392749
Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes MellitusQ44609117
Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial.Q50962089
The RAND 36-Item Health Survey 1.0.Q53676093
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American SociQ56773058
Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE).Q64884252
P433issue21
P407language of work or nameEnglishQ1860
P921main subjectbariatric surgeryQ357503
P304page(s)2002-2013
P577publication date2014-03-31
P1433published inThe New England Journal of MedicineQ582728
P1476titleBariatric surgery versus intensive medical therapy for diabetes--3-year outcomes
P478volume370

Reverse relations

cites work (P2860)
Q8901796530-Day Outcomes of Revisional Bariatric Stapling Procedures: First Report Based on MBSAQIP Data Registry
Q51744766A 4-Week Preoperative Ketogenic Micronutrient-Enriched Diet Is Effective in Reducing Body Weight, Left Hepatic Lobe Volume, and Micronutrient Deficiencies in Patients Undergoing Bariatric Surgery: a Prospective Pilot Study.
Q53196873A Challenge between Trainee Education and Patient Safety: Does Fellow Participation Impact Postoperative Outcomes Following Bariatric Surgery?
Q57171210A Longer Biliopancreatic Limb in Roux-en-Y Gastric Bypass Improves Weight Loss in the First Years After Surgery: Results of a Randomized Controlled Trial
Q48035253A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy
Q53778202A Prospective Randomized Controlled Trial of the Metabolic Effects of Sleeve Gastrectomy with Transit Bipartition.
Q39434406A Simple Food-Diverting Operation for Type 2 Diabetes Treatment. Preliminary Results in Humans with BMI 28-32 kg/m2.
Q26744812A Systematic Review and Meta-Analysis of Outcomes for Type 1 Diabetes after Bariatric Surgery
Q36360575A case of severe anorexia, excessive weight loss and high peptide YY levels after sleeve gastrectomy
Q34103558A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?
Q47137408A novel approach to glycemic control in type 2 diabetes mellitus, partial jejunal diversion: pre-clinical to clinical pathway
Q35534520A novel multidisciplinary intervention for long-term weight loss and glycaemic control in obese patients with diabetes
Q47903226A qualitative study of the role of Australian general practitioners in the surgical management of obesity
Q47138367A working paradigm for the treatment of obesity in gastrointestinal practice
Q46084030ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management
Q61905346ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management
Q61905355ASGE EndoVators Summit: defining the role and value of endoscopic therapies in obesity management
Q57450753ASMBS pediatric metabolic and bariatric surgery guidelines, 2018
Q47256071Ablation of the Duodenal Mucosa as a Strategy for Glycemic Control in Type 2 Diabetes: Role of Nutrient Signaling or Simple Weight Loss
Q36060744Activation of bile acid signaling improves metabolic phenotypes in high-fat diet-induced obese mice
Q30360570Adults with long-duration type 2 diabetes have blunted glycemic and β-cell function improvements after bariatric surgery.
Q90396286Alterations of Gastric Emptying Features Following Laparoscopic Sleeve Gastrectomy in Chinese Patients with Obesity: a Self-Controlled Observational Study
Q39434454Anaesthetic Preparation of Obese Patients: Current Status on Optimal Work-up
Q87998343Anemia and Bariatric Surgery: Results of a National French Survey on Administrative Data of 306,298 Consecutive Patients Between 2008 and 2016
Q37322475Application of side-to-side anastomosis of the lesser curvature of stomach and jejunum in gastric bypass
Q27008820Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose?
Q57394351Assessment of mammographic breast density after sleeve gastrectomy
Q49951864Association Between Bariatric Surgery and Rates of Continuation, Discontinuation, or Initiation of Antidiabetes Treatment 6 Years Later
Q38258985Association of race and socioeconomic status with outcomes following laparoscopic Roux-en-Y gastric bypass
Q34490397Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery
Q87318377Balancing risks and benefits of bariatric surgery for type 2 diabetes
Q35695556BariSurg trial: Sleeve gastrectomy versus Roux-en-Y gastric bypass in obese patients with BMI 35-60 kg/m(2) - a multi-centre randomized patient and observer blind non-inferiority trial
Q89004401Bariatric Arterial Embolization for Obesity: A Review of Early Clinical Evidence
Q45934116Bariatric Embolization of the Left Gastric Arteries for the Treatment of Obesity: 9-Month Data in 5 Patients.
Q35566022Bariatric Surgery Induces Disruption in Inflammatory Signaling Pathways Mediated by Immune Cells in Adipose Tissue: A RNA-Seq Study
Q33551839Bariatric Surgery Prior to Index Screening Colonoscopy Is Associated With a Decreased Rate of Colorectal Adenomas in Obese Individuals
Q47677805Bariatric Surgery Provides a "Bridge to Transplant" for Morbidly Obese Patients with Advanced Heart Failure and May Obviate the Need for Transplantation
Q36005792Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes.
Q38398940Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Second IFSO Global Registry Report 2013-2015.
Q40229384Bariatric Surgery and Kidney-Related Outcomes.
Q33711409Bariatric Surgery and Liver Transplantation
Q39436582Bariatric Surgery and Long-term Durability of Weight Loss
Q39417384Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy
Q41513392Bariatric Surgery for Type 2 Diabetes: Getting Closer to the Long-term Goal
Q47325007Bariatric Surgery in Obese Patients with Type 1 Diabetes: Effects on Weight Loss and Metabolic Control
Q35875543Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care
Q38960171Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes
Q38572077Bariatric Surgery versus Intensive Medical Weight Management for Type 2 Diabetes.
Q49899707Bariatric Surgery: A Perspective for Primary Care
Q38661024Bariatric Surgery: The Future of Obesity Management in Adolescents
Q38410200Bariatric and metabolic surgery: a shift in eligibility and success criteria
Q60907570Bariatric surgery among patients with heart failure: a systematic review and meta-analysis
Q26783213Bariatric surgery and diabetes remission: Who would have thought it?
Q39085972Bariatric surgery and diabetic retinopathy: a systematic review and meta-analysis of controlled clinical studies
Q64262531Bariatric surgery and hypertension: implications and perspectives after the GATEWAY randomized trial
Q91069213Bariatric surgery and type 2 diabetes: a step closer to defining an optimal approach
Q36163431Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass?
Q39023968Bariatric surgery for obesity and metabolic disorders: state of the art.
Q37017318Bariatric surgery is associated with improvement in kidney outcomes.
Q50083483Bariatric surgery reduces fasting total fatty acids and increases n-3 polyunsaturated fatty acids in morbidly obese individuals
Q42431844Bariatric surgery saves lives
Q35749702Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study
Q42795731Bariatric surgery: an attractive therapeutic modality for type 2 diabetes mellitus
Q53344977Bariatric surgery: time to move beyond clinical outcomes.
Q36784484Bariatric surgery: traversing the CROSSROADS into mainstream diabetes care
Q47965626Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial
Q36930271Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2
Q39145500Beneficial Effects of a Dietary Weight Loss Intervention on Human Gut Microbiome Diversity and Metabolism Are Not Sustained during Weight Maintenance
Q98178564Bile Acids: Key Regulators and Novel Treatment Targets for Type 2 Diabetes
Q92747716Bile Diversion Improves Metabolic Phenotype Dependent on Farnesoid X Receptor (FXR)
Q39228891Bile acids and bariatric surgery
Q27020976Bile acids, obesity, and the metabolic syndrome
Q35703158Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery.
Q37513457Blockade of Central GLP-1 Receptors Deteriorates the Improvement of Diabetes after Ileal Transposition
Q36911487C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery
Q34680490CORRELATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND FEATURES OF METABOLIC SYNDROME IN MORBIDLY OBESE PATIENTS IN THE PREOPERATIVE ASSESSMENT FOR BARIATRIC SURGERY.
Q60614572Cardiac Prevention Guidelines
Q51743643Cardiometabolic Effects of Anti-obesity Pharmacotherapy.
Q61950936Cardiometabolic Profile Related to Body Adiposity Identifies Patients Eligible for Bariatric Surgery More Accurately than BMI
Q35592620Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome
Q38412110Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study
Q38985963Cardiovascular effects of bariatric surgery
Q38430788Cardiovascular, renal and overall health outcomes after bariatric surgery.
Q48103365Central Modulation of Energy Homeostasis and Cognitive Performance After Bariatric Surgery
Q27331844Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies
Q39076089Changes in Fasting and Prandial Gut and Adiposity Hormones Following Vertical Sleeve Gastrectomy or Roux-en-Y-Gastric Bypass: an 18-Month Prospective Study
Q50430964Changes in adiposity and other cardiometabolic risk factors following Roux-en-Y gastric bypass: A 12-month prospective cohort study in Chinese patients
Q51294308Changes in insulin sensitivity and secretion after sleeve gastrectomy.
Q42174394Changes in regional body composition over 8 years in a randomized lifestyle trial: The look AHEAD study
Q41145464Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study
Q41909990Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.
Q47332999Circulating ANGPTL8/Betatrophin Concentrations Are Increased After Surgically Induced Weight Loss, but Not After Diet-Induced Weight Loss
Q38572961Clinical Management of Type 2 Diabetes Mellitus after Bariatric Surgery
Q39737868Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes
Q38843881Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications
Q37011769Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations
Q45128866Clinical course of diabetes after gastrectomy according to type of reconstruction in patients with concurrent gastric cancer and type 2 diabetes
Q35070830Clinician's guide to the updated ABCs of cardiovascular disease prevention
Q42082791Combination therapy with GLP-1 analogues and SGLT-2 inhibitors in the management of diabesity: the real world experience.
Q86089829Comment on: Is glycosylated hemoglobin A1 c associated with increased risk for severe early postoperative complications in nondiabetics after laparoscopic gastric bypass?
Q89451135Comparative Characteristics of Patients with Type 2 Diabetes Mellitus Treated by Bariatric Surgery Versus Medical Treatment: a Multicentre Analysis of 277,862 Patients from the German/Austrian DPV Database
Q37127390Comparative effectiveness and safety of gastric bypass, sleeve gastrectomy and adjustable gastric banding in a population-based bariatric program: prospective cohort study.
Q57111820Comparison of Great Curvature Plication with Duodenal-Jejunal Bypass (GCP-DJB) and Sleeve Gastrectomy (SG) on Metabolic Indices and Gut Hormones in Type 2 Diabetes Mellitus Rats
Q47738963Comparison of Outcomes Between Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in a Lebanese Bariatric Surgical Practice
Q88034892Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents
Q37717858Comparison of consumption behavior and appetite sensations among patients with type 2 diabetes mellitus after bariatric surgery
Q38211505Control of type 2 diabetes after 1 year of laparoscopic adjustable gastric banding in the helping evaluate reduction in obesity (HERO) study
Q38358945Controversies in bariatric surgery
Q64248633Cost-Effectiveness Evaluation of Bariatric Surgery for Morbidly Obese with Diabetes Patients in Thailand
Q41136739Cost-effectiveness of gastric band surgery for overweight but not obese adults with type 2 diabetes in the U.S.
Q90465244Current and Future Endoscopic Weight Loss Solutions
Q56343202Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
Q47666230Customization of bilio-pancreatic limb length to modulate and sustain anti-diabetic effect of gastric bypass surgery
Q65001046De vuelta a la clínica: sin justificación no existe pregunta de investigación que valga.
Q41040405Decreased Cardiovascular Risk after Roux-en-Y Gastric Bypass Surgery in Chinese Diabetic Patients with Obesity
Q37639541Decreased Levels of Circulating Cancer-Associated Protein Biomarkers Following Bariatric Surgery.
Q47558223Design and Clinical Evaluation of a Novel Low-Glucose Prediction Algorithm with Mini-Dose Stable Glucagon Delivery in Post-Bariatric Hypoglycemia
Q55398988Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I): a randomised controlled trial to examine the impact of an intensive lifestyle intervention consisting of a low-energy diet and physical activity on body weight and metaboli
Q38812184Diabetes after Bariatric Surgery
Q42248824Diabetes recurrence after metabolic surgeries correlates with re-impaired insulin sensitivity rather than beta-cell function
Q56977501Diabetes remission and relapse after metabolic surgery
Q87686119Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy
Q87845901Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy. Reply to Halpern B, Cercato C, Mancini MC [letter]
Q38648297Diarrhea after bariatric procedures: Diagnosis and therapy.
Q53765904Differences in Anthropometric and Metabolic Parameters Between Subjects with Hypoglycaemia and Subjects with Euglycaemia After an Oral Glucose Tolerance Test Six Months After Laparoscopic Sleeve Gastrectomy.
Q30277979Differences in Weight Loss and Gut Hormones: Rouen-Y Gastric Bypass and Sleeve Gastrectomy Surgery
Q64233406Differential composition of gut microbiota among healthy volunteers, morbidly obese patients and post-bariatric surgery patients
Q91871803Discordance in prediction for prognosis of type 2 diabetes after metabolic surgery: comparison of the ABCD, DiaRem, and individualized metabolic surgery models
Q33824299Distinct patterns in the gut microbiota after surgical or medical therapy in obese patients
Q38639436Do Food Preferences Change After Bariatric Surgery?
Q55220546Does Gastric Surgery (Such as Bariatric Surgery) Impact the Risk of Intestinal Inflammation?
Q55339136Does bariatric surgery influence plasma levels of fetuin-A and leukocyte cell-derived chemotaxin-2 in patients with type 2 diabetes mellitus?
Q88747509Downregulation of lncRNA MALAT1 contributes to renal functional improvement after duodenal-jejunal bypass in a diabetic rat model
Q36068612Duodenal stump leak following a duodenal switch: A case report
Q57104599Duodenal-Jejunal Bypass Preferentially Elevates Serum Taurine-Conjugated Bile Acids and Alters Gut Microbiota in a Diabetic Rat Model
Q40696946Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial
Q55497819EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.
Q60462090EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Q86872308Early Postoperative Outcomes of Primary Bariatric Surgery in Patients on Chronic Steroid or Immunosuppressive Therapy
Q26824144Early onset type 2 diabetes: risk factors, clinical impact and management
Q47563194Effect of Bariatric Surgery on CKD Risk
Q41117717Effect of Early Use of Covered Self-Expandable Endoscopic Stent on the Treatment of Postoperative Stapler Line Leaks
Q37587252Effect of Laparoscopic Sleeve Gastrectomy on Fasting Gastrointestinal, Pancreatic, and Adipose-Derived Hormones and on Non-Esterified Fatty Acids.
Q50886155Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class.
Q49702411Effect of Roux-en-Y Gastric Bypass on the NLRP3 Inflammasome in Pancreatic Islets from Zucker Diabetic Fatty Rats
Q36405830Effect of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding on gastrointestinal metabolism of ingested glucose
Q51299591Effect of Sleeve Gastrectomy Plus Side-to-Side Jejunoileal Anastomosis for Type 2 Diabetes Control in an Obese Rat Model.
Q36327719Effect of bariatric surgery on cardiometabolic risk in elderly patients: A population-based study
Q47387845Effect of bariatric surgery on diabetic nephropathy in obese type 2 diabetes patients in a retrospective 2-year study: A local pilot
Q55046907Effect of gastric bypass combined with ileal transportation on type 2 diabetes mellitus.
Q38625348Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis
Q50125577Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study
Q36639808Effectiveness and safety of laparoscopic Roux-en-Y gastric bypass for the treatment of type 2 diabetes mellitus
Q52660011Effectiveness of an Interprofessional Glycemic Optimization Clinic on Preoperative Glycated Hemoglobin Levels for Adult Patients with Type 2 Diabetes Undergoing Bariatric Surgery.
Q47789013Effects of Bariatric Surgery on Change of Brown Adipocyte Tissue and Energy Metabolism in Obese Mice
Q38780759Effects of Bariatric Surgery on Mortality, Cardiovascular Events, and Cancer Outcomes in Obese Patients: Systematic Review and Meta-analysis
Q48346217Effects of Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in an Obese Rat Model
Q35731755Effects of an eight-week supervised, structured lifestyle modification programme on anthropometric, metabolic and cardiovascular risk factors in severely obese adults.
Q58167278Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery
Q89928292Efficacy and Safety of Endoscopic Sleeve Gastroplasty at Mid Term in the Management of Overweight and Obese Patients: a Systematic Review and Meta-Analysis
Q92243626Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial
Q48137462Efficacy of Bariatric Surgery in Type 2 Diabetes Mellitus Remission: the Role of Mini Gastric Bypass/One Anastomosis Gastric Bypass and Sleeve Gastrectomy at 1 Year of Follow-up. A European survey.
Q59043926Endogenous Glucagon-Like Peptide-1 as a Potential Mediator of the Resolution of Diabetic Kidney Disease following Roux en Y Gastric Bypass: Evidence and Perspectives
Q30240029Endoscopic Bariatric and Metabolic Therapies: Surgical Analogues and Mechanisms of Action
Q38817948Endoscopic Devices for Obesity
Q47779748Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up
Q92090714Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study
Q37143824Energy restriction and Roux-en-Y gastric bypass reduce postprandial α-dicarbonyl stress in obese women with type 2 diabetes
Q88669521Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor
Q40436924Estimated GFR Before and After Bariatric Surgery in CKD.
Q47094048European Guidelines for Obesity Management in Adults.
Q57687713European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, Sweden, June 1 - 4, 2016: Abstracts
Q91643597Evaluation of the Diabetes Regional Coordination Path using the Diabetes Coordination Notebook in community-based diabetes care
Q46747015Expanded indications for bariatric surgery: should patients on chronic steroids be offered bariatric procedures?
Q40034159Experiences of accessing obesity surgery on the NHS: a qualitative study
Q36425655Facilitated long chain fatty acid uptake by adipocytes remains upregulated relative to BMI for more than a year after major bariatric surgical weight loss
Q38659973Factors Associated With Achieving a Body Mass Index of Less Than 30 After Bariatric Surgery
Q36730322Failed Surgical Weight Loss Does Not Necessarily Mean Failed Metabolic Effects
Q33608036Five-year outcomes of laparoscopic sleeve gastrectomy as a primary procedure for morbid obesity: A prospective study
Q35630856Foregut exclusion disrupts intestinal glucose sensing and alters portal nutrient and hormonal milieu
Q41078463Functional Liver Recovery After Bariatric Surgery--a Prospective Cohort Study with the LiMAx Test
Q38307449GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?
Q52916575Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker Rat.
Q36784428Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial
Q50956202Gastrin Secretion After Bariatric Surgery-Response to a Protein-Rich Mixed Meal Following Roux-En-Y Gastric Bypass and Sleeve Gastrectomy: a Pilot Study in Normoglycemic Women.
Q33464423Gastro-intestinal Quality of Life After Metabolic Surgery for the Treatment of Type 2 Diabetes Mellitus
Q35994552Gastrointestinal traits: individualizing therapy for obesity with drugs and devices
Q33624161Gastropleural fistula after single anastomosis gastric bypass. A case report and review of the literature
Q89978484Global Mapping of Interventions to Improve Quality of Life of People with Diabetes in 1990-2018
Q47249342Glucose Metabolism After Gastric Banding and Gastric Bypass in Individuals With Type 2 Diabetes: Weight Loss Effect
Q48372455Glycemic Control after Sleeve Gastrectomy and Roux-En-Y Gastric Bypass in Obese Subjects with Type 2 Diabetes Mellitus.
Q47935352Glycemic control after metabolic surgery: a Granger causality and graph analysis
Q30235568Gut-Brain Cross-Talk in Metabolic Control
Q48013884Health-Related Quality of Life after Bariatric Surgery and its Correlation with Glycaemic Status in Hong Kong Chinese Adults
Q52770258Heterogeneity of proliferative markers in pancreatic β-cells of patients with severe hypoglycemia following Roux-en-Y gastric bypass.
Q38559029How Durable Are the Effects After Metabolic Surgery?
Q26741527How do patients' clinical phenotype and the physiological mechanisms of the operations impact the choice of bariatric procedure?
Q50180316How safe is metabolic/diabetes surgery?
Q47192153Hypertension in Obesity and the Impact of Weight Loss
Q35902704Hypovitaminosis D in bariatric surgery: A systematic review of observational studies
Q38291812IFN-γ secretion in gut of Ob/Ob mice after vertical sleeve gastrectomy and its function in weight loss mechanism
Q48223445Identifying Barriers to Appropriate Use of Metabolic/Bariatric Surgery for Type 2 Diabetes Treatment: Policy Lab Results.
Q38263804Imaging of atherosclerotic plaques in obesity: excessive fat accumulation, plaque progression and vulnerability
Q48198369Immediate Metabolic Response Following Sleeve Gastrectomy in Obese Diabetics.
Q38720579Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea: A Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis
Q41043481Impact of sleeve gastrectomy verses sleeve gastrectomy plus side-to-side jejunoileal anastomosis on weight loss and metabolic control in an obese rat model.
Q85410715Improvement in severe pulmonary hypertension in obese patients after laparoscopic gastric bypass or sleeve gastrectomy
Q35012062Improvement of diabetes and hypertension after gastrectomy: a nationwide cohort study
Q38236210Improvements in the metabolic milieu following Roux-en-Y gastric bypass and the arrest of diabetic kidney disease.
Q50434312Improvements of Glucose and Lipid Metabolism After Jejuno-ileal Circuit Procedure in a Non-obese Diabetic Rat Model
Q33662245Increased β-Cell Mass in Obese Rats after Gastric Bypass: A Potential Mechanism for Improving Glycemic Control.
Q47289520Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).
Q38580991Inpatient Glycemic Protocol for Patients with Diabetes Undergoing Bariatric Surgery.
Q42502977Insulin Sensitivity and Secretion in Obese Type 2 Diabetic Women after Various Bariatric Operations
Q36830607Insulin Sensitivity and β-Cell Function Improve after Gastric Bypass in Severely Obese Adolescents
Q28072225Interaction of obesity and inflammatory bowel disease
Q47977321Iron-Deficiency Anemia After Laparoscopic Roux-en-Y Gastric Bypass in Chinese Obese Patients with Type 2 Diabetes: a 2-Year Follow-Up Study
Q36686998Is Bariatric Surgery an Effective Treatment for Type II Diabetic Kidney Disease?
Q47731656Is Mini-Gastric Bypass a Rational Approach for Type-2 Diabetes?
Q94476043Is Roux-en-Y gastric bypass advantageous?-surgical outcomes in obese patients with type-2 diabetes after gastric bypass versus sleeve gastrectomy, a matched retrospective study
Q51297760Is a Simple Food-Diverting Operation the Solution for Type 2 Diabetes Treatment? Experimental Study in a Non-Obese Rat Model.
Q55069710Japanese Clinical Practice Guideline for Diabetes 2016.
Q40632431LAP-BAND for BMI 30-40: 5-year health outcomes from the multicenter pivotal study
Q92025285Laparoendoscopic Single-Site Bariatric Surgery: A Review of Single-Port Laparoscopic and Endoscopic Bariatric Treatments
Q48255876Laparoscopic Roux-En-Y Gastric Bypass Improves Lipid Profile and Decreases Cardiovascular Risk: a 5-Year Longitudinal Cohort Study of 1048 Patients
Q38576004Laparoscopic Roux-en-Y gastric bypass patients have an increased lifetime risk of repeat operations when compared to laparoscopic sleeve gastrectomy patients
Q33717458Laparoscopic Roux-en-Y gastric bypass versus laparoscopic mini gastric bypass in the treatment of obesity: study protocol for a randomized controlled trial
Q37634009Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS).
Q38707776Laparoscopic Sleeve Gastrectomy for the Management of Type 1 Diabetes Mellitus.
Q40517387Laparoscopic gastric bypass surgery: a safe and effective operation for the ≥60s?
Q41530753Laparoscopic hand-sewn revisional gastrojejunal plication for weight loss failure after Roux-en-Y gastric bypass
Q26784214Laparoscopic sleeve gastrectomy and gastroesophageal reflux
Q37409953Laparoscopic sleeve gastrectomy for the treatment of diabetes mellitus type 2 patients-single center early experience.
Q88155293Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect
Q26778002Laparoscopic sleeve gastrectomy: More than a restrictive bariatric surgery procedure?
Q37591734Late presentation of fatal hyperammonemic encephalopathy after Roux-en-Y gastric bypass
Q36131813Leptin Is Required for Glucose Homeostasis after Roux-en-Y Gastric Bypass in Mice
Q36028309Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery
Q35109151Lifestyle and diet
Q38241747Lifestyle management for enhancing outcomes after bariatric surgery.
Q53144975Lithium toxicity after Roux-en-Y bariatric surgery.
Q35783949Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology
Q47661409Long-Term (over 10 Years) Retrospective Follow-up of Laparoscopic Adjustable Gastric Banding.
Q89670008Long-Term (over 13 Years) Follow-Up of Vertical Band Gastroplasty
Q54314693Long-Term Outcomes of Three Types of Bariatric Surgery on Obesity and Type 2 Diabetes Control and Remission.
Q47136824Long-term Follow-up for Type 2 Diabetes Mellitus after Gastrectomy in Non-morbidly Obese Patients with Gastric Cancer: the Legitimacy of Onco-metabolic Surgery
Q87934555Long-term Metabolic Effects of Laparoscopic Sleeve Gastrectomy
Q41862134Long-term Microvascular Disease Outcomes in Patients With Type 2 Diabetes After Bariatric Surgery: Evidence for the Legacy Effect of Surgery.
Q35704093Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2).
Q38705488Long-term follow-up after bariatric surgery in a national cohort
Q38753187Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study
Q49850570Long-term outcomes of patients undergoing simultaneous Liver Transplantation and Sleeve Gastrectomy.
Q38880154Long-term pharmacotherapy considerations in the bariatric surgery patient
Q37550281Longer-Term Physiological and Metabolic Effects of Gastric Bypass Surgery
Q41949952Low carbohydrate diet-based intervention for obstructive sleep apnea and primary hypothyroidism in an obese Japanese man.
Q26784112MANAGEMENT OF ENDOCRINE DISEASE: Metabolic effects of bariatric surgery
Q37339631MASTICATORY FUNCTION OF OBESE CANDIDATES TO BARIATRIC SURGERY FROM DISTINCT SOCIOECONOMIC CLASSES.
Q38389493MILEPOST Multicenter Randomized Controlled Trial: 12-Month Weight Loss and Satiety Outcomes After pose SM vs. Medical Therapy
Q58617966MRI assessment of changes in adipose tissue parameters after bariatric surgery
Q57026285Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Q40236660Management of Type 2 Diabetes in the Setting of Morbid Obesity: How Can Weight Gain Be Prevented or Reversed?
Q56979722Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Q34513665Management of obesity
Q34106367Managing overweight and obesity in adults to reduce cardiovascular disease risk
Q37212797Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe
Q57119456Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different
Q34898952Mechanisms underlying weight loss and metabolic improvements in rodent models of bariatric surgery
Q30238940Medical Management of Diabesity: Do We Have Realistic Targets?
Q41485058Medium-Term Results of Laparoscopic Sleeve Gastrectomy: a Matched Comparison with Gastric Bypass
Q36132127Meta-analysis of bariatric surgery versus non-surgical treatment for type 2 diabetes mellitus
Q57116100Metabolic Surgery and Diabesity: a Systematic Review
Q48018388Metabolic Surgery for Diabetes Treatment: Sleeve Gastrectomy or Gastric Bypass?
Q28069918Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia
Q36930263Metabolic Surgery for Type 2 Diabetes: Changing the Landscape of Diabetes Care
Q57117141Metabolic Surgery for the Treatment of Diabetes Mellitus Positioning of Leading Medical Associations in Mexico
Q38572963Metabolic Surgery in Type 2 Diabetes: Roux-en-Y Gastric Bypass or Sleeve Gastrectomy as Procedure of Choice?
Q51841828Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations.
Q90680826Metabolic and Endocrine Consequences of Bariatric Surgery
Q34471033Metabolic bariatric surgery and type 2 diabetes mellitus: an endocrinologist's perspective
Q91445282Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes
Q39369814Micronutrient Deficiencies After Bariatric Surgery: An Emphasis on Vitamins and Trace Minerals [Formula: see text].
Q90010138Micronutrient Deficiencies After Roux-en-Y Gastric Bypass: Long-Term Results
Q37598327Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial
Q39680433Mid-Term Remission of Type 2 Diabetes Mellitus After Laparoscopic Roux En-Y Gastric Bypass.
Q39022546Milestone Weight Loss Goals (Weight Normalization and Remission of Obesity) after Gastric Bypass Surgery: Long-Term Results from the University of Michigan
Q35140176Mini-gastric bypass to control morbid obesity and diabetes mellitus: what radiologists need to know
Q91179582Mitochondrial dynamics in skeletal muscle insulin resistance and type 2 diabetes
Q38249884Modern obesity pharmacotherapy: weighing cardiovascular risk and benefit
Q33600478Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
Q90352316Mortality after bariatric surgery: findings from a 7-year multicenter cohort study
Q33600044National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30-35 kg/m2).
Q36624963Nationwide Survey on Bariatric and Metabolic Surgery in Korea: 2003-2013 Results
Q57114860New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
Q38211754New pharmacological treatments for the management of obesity
Q90304117No Difference in Ghrelin-Producing Cell Expression in Obese Versus Non-obese Stomach: a Prospective Histopathological Case-Control Study
Q57822734Non-pharmacological Treatment Options in the Management of Diabetes Mellitus
Q38259507Novel therapeutics for type 2 diabetes: insulin resistance
Q88317935Obesity
Q57673205Obesity and Type 2 Diabetes
Q26784097Obesity and liver transplantation
Q37604957Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry
Q30249819Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.
Q48698019Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment
Q38514840Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones
Q92497883Opportunities and challenges in the therapeutic activation of human energy expenditure and thermogenesis to manage obesity
Q49360043Optimisation of follow-up after metabolic surgery
Q37429182Outcomes associated with preoperative weight loss after laparoscopic Roux-en-Y gastric bypass
Q58608335Outcomes of Bariatric Surgery Versus Medical Management for Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Controlled Trials
Q46335474Outcomes of One Anastomosis Gastric Bypass in 472 Diabetic Patients
Q51315185Outcomes of bariatric surgery in type 2 diabetic patients with diminished pancreatic secretory reserve.
Q42697143Partitioning of adipose lipid metabolism by altered expression and function of PPAR isoforms after bariatric surgery
Q39154018Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension
Q27692586Patient and Referring Practitioner Characteristics Associated With the Likelihood of Undergoing Bariatric Surgery: A Systematic Review
Q45326265Patient predictors of weight loss following a behavioral weight management intervention among US Veterans with severe obesity.
Q58447132Patient profiling for success after weight loss surgery (GO Bypass study): An interdisciplinary study protocol
Q90183863Patient-reported outcomes for heart failure with preserved ejection fraction: conducting quality studies on quality of life
Q47549919Patient-reported quality of life after bariatric surgery: a single institution analysis.
Q46832065Patterns of Weight Loss Response Following Gastric Bypass and Sleeve Gastrectomy
Q30241654Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children
Q102369352Peri-operative antibiotics acutely and significantly impact intestinal microbiota following bariatric surgery
Q38734496Perioperative Glycemic Management of Patients Undergoing Bariatric Surgery
Q48100757Perioperative Short-Term Outcome in Super-Super-Obese Patients Undergoing Bariatric Surgery.
Q35204654Peripheral mechanisms in appetite regulation
Q38965089Physiological and molecular responses to bariatric surgery: markers or mechanisms underlying T2DM resolution?
Q30374407Pleiotropic effects of type 2 diabetes management strategies on renal risk factors.
Q47915318Polycystic ovary syndrome throughout a woman's life
Q53602917Postoperative Outcomes of Laparoscopic Bariatric Surgery in Older Obese Patients: a Matched Case-Control Study.
Q47184395Postoperative Outcomes, Weight Loss Predictors, and Late Gastrointestinal Symptoms Following Laparoscopic Sleeve Gastrectomy
Q57470802Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes
Q38363114Potential mechanisms mediating improved glycemic control after bariatric/metabolic surgery
Q38232790Predicting remission of diabetes after RYGB surgery following intensive management to optimize preoperative glucose control
Q37683234Prediction Model for Hemorrhagic Complications after Laparoscopic Sleeve Gastrectomy: Development of SLEEVE BLEED Calculator.
Q38552984Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass.
Q92025427Prediction of Type 2 Diabetes Remission after Bariatric or Metabolic Surgery
Q48220785Predictive Value of Gut Peptides in T2D Remission: Randomized Controlled Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy and Greater Curvature Plication
Q90254057Predictive factors for diabetes remission after bariatric surgery
Q35816567Predictors of Postoperative Aftercare Attrition among Gastric Bypass Patients
Q41117540Predictors of long-term diabetes remission after metabolic surgery
Q99551273Predictors of normalized HbA1c after gastric bypass surgery in subjects with abnormal glucose levels, a 2-year follow-up study
Q40606981Predictors of readmission after laparoscopic gastric bypass and sleeve gastrectomy: a comparative analysis of ACS-NSQIP database
Q95558388Preoperative Prediction of Type 2 Diabetes Remission After Gastric Bypass Surgery: a Comparison of DiaRem Scores and ABCD Scores
Q58447498Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery
Q89816434Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model
Q40050350Prevalence and Trends in Lifetime Obesity in the U.S., 1988-2014.
Q92988144Prevalence of hypoglycaemia in a random population after Roux-en-Y gastric bypass after a meal test
Q50055665Quality indicators for metabolic and bariatric surgery in Germany : Evidence-based development of an indicator panel for the quality of results, indications and structure
Q88112470Quality of Life After Bariatric Surgery
Q47222630RYGB Produces more Sustained Body Weight Loss and Improvement of Glycemic Control Compared with VSG in the Diet-Induced Obese Mouse Model.
Q36505804RYGB progressively increases avidity for a low-energy, artificially sweetened diet in female rats
Q92647262Randomized clinical trial of an enhanced recovery after surgery programme versus conventional care in laparoscopic Roux-en-Y gastric bypass surgery
Q37633938Recent Trends in Endoscopic Bariatric Therapies
Q28083094Recent advances in bariatric/metabolic surgery: appraisal of clinical evidence
Q26745203Recent advances in metabolic and bariatric surgery
Q38849378Recent advances in the modification of taste and food preferences following bariatric surgery.
Q38811941Reconciliation of Type 2 Diabetes Remission Rates in Studies of Roux-en-Y Gastric Bypass
Q38950084Reduced inflammatory responses of follicular helper T cell promote the development of regulatory B cells after Roux-en-Y gastric bypass
Q38607538Reduction of Framingham BMI score after rapid weight loss in severely obese subjects undergoing sleeve gastrectomy: a single institution experience
Q88799890Relationship Between Vitamin D Deficiency and the Components of Metabolic Syndrome in Patients with Morbid Obesity, Before and 1 Year After Laparoscopic Roux-en-Y Gastric Bypass or Sleeve Gastrectomy
Q27022123Relationship between gut hormones and glucose homeostasis after bariatric surgery
Q93078585Remission of Type 2 Diabetes Mellitus after Bariatric Surgery: Fact or Fiction?
Q38263768Remission of type 2 diabetes: is bariatric surgery ready for prime time?
Q37595227Renal Function in Type 2 Diabetes Following Gastric Bypass
Q40534235Reproductive Outcomes Differ Following Roux-en-Y Gastric Bypass and Adjustable Gastric Band Compared with Those of an Obese Non-Surgical Group
Q57108067Rethinking Bile Acid Metabolism and Signaling for Type 2 Diabetes Treatment
Q41171964Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery
Q38843488Revisional Bariatric/Metabolic Surgery: What Dictates Its Indications?
Q41026213Risk of Malnutrition, Trace Metal, and Vitamin Deficiency Post Roux-en-Y Gastric Bypass--a Prospective Study of 20 Patients with BMI < 35 kg/m².
Q57808816Risk of Suicide and Self-harm Is Increased After Bariatric Surgery-a Systematic Review and Meta-analysis
Q37033642Risk of post-gastric bypass surgery hypoglycemia in nondiabetic individuals: A single center experience
Q39256982Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes.
Q37639656Role of the Gut on Glucose Homeostasis: Lesson Learned from Metabolic Surgery
Q37188048Roux-En Y Gastric Bypass Results in Long-Term Remission of Hepatocyte Apoptosis and Hepatic Histological Features of Non-alcoholic Steatohepatitis.
Q47821671Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity: a Systematic Review and Meta-analysis.
Q37206402Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Q35771371Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial
Q37278829Roux-en-Y gastric bypass surgery is effective in fibroblast growth factor-21 deficient mice.
Q33923792STAMPEDE: Bariatric surgery gains more evidence based support
Q40489457Safety analysis of primary bariatric surgery in patients on chronic dialysis
Q47581286Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients
Q88634575Selection of Bypass vs Sleeve for the Management of Type-2 Diabetes in Severely Obese: Could Ethnicity Play a Role?
Q40093246Self-harm and suicide after bariatric surgery: time for action
Q57062777Serum FABP4 concentrations decrease after Roux-en-Y gastric bypass but not after intensive medical management
Q45539867Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study
Q38973619Signals from the gut microbiota to distant organs in physiology and disease
Q36550718Simplified gastric bypass: 13 years of experience and 12,000 patients operated
Q89643061Single Anastomosis Duodenal Switch: 1-Year Outcomes
Q50051028Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-world Population
Q38912733Single-Anastomosis Pylorus-Preserving Bariatric Procedures: Review of the Literature.
Q64956935Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a pro
Q47356519Sleeve Gastrectomy Decreases Body Weight, Whole-Body Adiposity, and Blood Pressure Even in Aged Diet-Induced Obese Rats
Q35832855Sleeve Gastrectomy Does Not Cause Hypertrophy and Reprogramming of Intestinal Glucose Metabolism in Rats
Q47620617Sleeve Gastrectomy Outcomes in Patients with BMI Between 30 and 35-3 Years of Follow-Up
Q47356999Sleeve Gastrectomy Reduces Body Weight and Improves Metabolic Profile also in Obesity-Prone Rats.
Q88742473Sleeve Gastrectomy and Diabetes: Is Cure Possible?
Q89758359Sleeve Gastrectomy enhances glucose utilization and remodels adipose tissue independent of weight loss
Q64066317Sleeve gastrectomy rapidly enhances islet function independently of body weight
Q51301524Sleeve gastrectomy, but not duodenojejunostomy, preserves total beta-cell mass in Goto-Kakizaki rats evaluated by three-dimensional optical projection tomography.
Q90627250Stapler-Less Robotic Partial Gastrectomy: a Safety and Feasibility Experimental Study
Q50231226Stigma and Knowledge as Determinants of Recommendation and Referral Behavior of General Practitioners and Internists
Q47285702Structured dietary intervention to facilitate weight loss after bariatric surgery: A randomized, controlled pilot study
Q38990059Successful Treatment of an Unusual Case of FPLD2: The Role of Roux-en-Y Gastric Bypass-Case Report and Literature Review.
Q38333573Surgery in the treatment of type 2 diabetes mellitus.
Q39030273Surgical Treatment of Metabolic Syndrome
Q42329519Surgical Treatment of Type 2 Diabetes
Q54438990Surgical advances in obese candidates and recipients.
Q51263392Surgical and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in Class I Obese Patients: a Short-Term Outcome.
Q30372129Surgical models of Roux-en-Y gastric bypass surgery and sleeve gastrectomy in rats and mice.
Q89109805Surgical treatment of obesity
Q38394137Surgical treatment of obesity: status quo
Q42928733Sympathetic inhibition after bariatric surgery
Q33907979TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice
Q92431618THE INFLUENCE OF TOTAL OR SUB-TOTAL GASTRECTOMY ON GLUCOSE CONTROL IN DIABETIC AND NON-DIABETIC PATIENTS
Q37339623THE ROLE OF METABOLIC SURGERY FOR PATIENTS WITH OBESITY GRADE I AND TYPE 2 DIABETES NOT CONTROLLED CLINICALLY.
Q38894976THE ROLE OF METABOLIC SURGERY FOR PATIENTS WITH OBESITY GRADE I ANDCLINICALLY UNCONTROLLED TYPE 2 DIABETES.
Q49304849THE ROLE OF THE SLEEVE GASTRECTOMY AND THE MANAGEMENT OF TYPE 2 DIABETES.
Q90654965Taste Changes after Bariatric Surgery: a Systematic Review
Q35577851Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes.
Q92046689Temporal plasticity of insulin and incretin secretion and insulin sensitivity following sleeve gastrectomy contribute to sustained improvements in glucose control
Q46358203Ten-year Outcomes of a Prospective Randomized Trial of Laparoscopic Gastric Bypass Versus Laparoscopic Gastric Banding
Q51306390The 10(th) Annual Cardiometabolic Health Congress General Session Highlights.
Q38910283The Bariatric Patient in the Intensive Care Unit: Pitfalls and Management
Q50644121The Diabetes Surgery Summit II Guidelines: a Disease-Based Clinical Recommendation.
Q28075888The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?
Q40922935The Effect of Weight Loss on Indigenous Australians with Diabetes: a study of Feasibility, Acceptability and Effectiveness of Laparoscopic Adjustable Gastric Banding.
Q89127173The Effectiveness of Endoscopic Gastroplasty for Obesity Treatment According to FDA Thresholds: Systematic Review and Meta-Analysis Based on Randomized Controlled Trials
Q48139356The IGF-Axis and Diabetic Retinopathy Before and After Gastric Bypass Surgery
Q36177694The Newfoundland and Labrador Bariatric Surgery Cohort Study: Rational and Study Protocol
Q53770143The Parabrachial Nucleus: CGRP Neurons Function as a General Alarm.
Q30249489The Role of Metabolic Surgery on Blood Pressure Control
Q33889594The Role of Sleeve Gastrectomy on Preventing Type 2 Diabetes Mellitus
Q36388487The Role of the Multidisciplinary Conference in the Evaluation of Bariatric Surgery Candidates with a High-Risk Psychiatric Profile
Q37359266The Saudi clinical practice guideline for the management of overweight and obesity in adults.
Q53438835The Science of Obesity Management: An Endocrine Society Scientific Statement.
Q35698046The Short-Term Remission of Diabetic Nephropathy After Roux-en-Y Gastric Bypass in Chinese Patients of T2DM with Obesity
Q47755685The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass
Q36032611The comprehensive summary of surgical versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials
Q38745483The contribution of rising adiposity to the increasing prevalence of diabetes in the United States
Q26783535The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones
Q47352216The effects of diet- and RYGB-induced weight loss on insulin sensitivity in obese patients with and without type 2 diabetes
Q87983913The effects of optimal perioperative glucose control on morbidly obese patients undergoing bariatric surgery
Q39435137The essential role of exercise in the management of type 2 diabetes.
Q37074338The evolving role of bariatric surgery in patients with type 1 diabetes and obesity
Q38793359The future of the Roux-en-Y gastric bypass
Q35376124The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence
Q38924361The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance
Q26767142The metabolic vascular syndrome - guide to an individualized treatment
Q35043446The physiology underlying Roux-en-Y gastric bypass: a status report
Q38709454The risk of kidney stones following bariatric surgery: a systematic review and meta-analysis
Q41363406The role of bariatric surgery to treat diabetes: current challenges and perspectives
Q35665486The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review.
Q86969104The rollercoaster of post-bariatric hypoglycaemia
Q39512020The safety of laparoscopic sleeve gastrectomy among diabetic patients.
Q36998556Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial
Q47896663Thrombin Generation Measurements in Patients Scheduled for Laparoscopic Bariatric Surgery
Q48778308Top 10 cardiovascular therapies and interventions for the next decade
Q52573286Totally endoscopic implant to effect a gastric bypass: 12-month safety and efficacy outcomes.
Q36956145Treatment of Obesity: Weight Loss and Bariatric Surgery
Q37110293Type 1 Diabetes Mellitus and Bariatric Surgery: A Systematic Review and Meta-Analysis
Q37025587Type 2 Diabetes Remission Rates After Laparoscopic Gastric Bypass and Gastric Banding: Results of the Longitudinal Assessment of Bariatric Surgery Study
Q48233341Type 2 diabetes mellitus outcomes after laparoscopic gastric bypass in patients with BMI <35 kg/m(2) using strict remission criteria: early outcomes of a prospective study among Mexicans
Q46364544Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores.
Q30276811Type 2 diabetes remission following gastric bypass: does diarem stand the test of time?
Q53535466Type 2 diabetes: multimodal treatment of a complex disease.
Q59795202Understanding the psychosocial impact of weight loss following bariatric surgery: a qualitative study
Q55004158Unraveling the compromised biomechanical performance of type 2 diabetes- and Roux-en-Y gastric bypass bone by linking mechanical-structural and physico-chemical properties.
Q38840514Use of Home Parenteral Nutrition in Post-Bariatric Surgery-Related Malnutrition
Q57797785Using the Minnesota Multiphasic Personality Inventory-2-Restructured Form Cutoffs to Predict Lack of Pre-surgical Exercise
Q34475450Vagal innervation of intestine contributes to weight loss After Roux-en-Y gastric bypass surgery in rats
Q24186730Vitamin D supplementation for obese adults undergoing bariatric surgery
Q88261815Weight Loss and Comorbidity Resolution 3 Years After Bariatric Surgery-an Indian Perspective
Q36736117Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents
Q34503739Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action
Q41698360Weight regain after Roux-en-Y gastric bypass has a large negative impact on the Bariatric Quality of Life Index.
Q55555487What Has Bariatric Surgery Taught Us About the Role of the Upper Gastrointestinal Tract in the Regulation of Postprandial Glucose Metabolism?
Q38655873What is the Mechanism Behind Weight Loss Maintenance with Gastric Bypass?
Q39067032What is the role of bariatric surgery in the management of obesity?
Q85786867[Clinical evidence for metabolic surgery]
Q85499934[Dumping syndrome: Diagnostics and therapeutic options]
Q53077298[Endoscopic treatment of obesity and complications following bariatric surgery].
Q85815704[Insulin or surgery? : the perspective of a diabetologist]
Q52786916[Metabolic surgery or conservative measures as therapy of obese type 2 diabetics?]
Q86629823[Pharmacological therapy versus bariatric surgery for patients with obesity and type 2 diabetes]
Q52872871[Procedure selection and technique of metabolic surgery].
Q53062719[Redo intervention and complication management in bariatric surgery].
Q27692665β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes
Q48243935γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery.

Search more.